16-89816615-T-G

Variant summary

Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong

The NM_000135.4(FANCA):ā€‹c.1A>Cā€‹(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000328 in 1,524,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0000066 ( 0 hom., cov: 34)
Exomes š‘“: 0.0000029 ( 0 hom. )

Consequence

FANCA
NM_000135.4 start_lost

Scores

6
3
7

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 0.666
Variant links:
Genes affected
FANCA (HGNC:3582): (FA complementation group A) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 20 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_000135.4 (FANCA) was described as [Pathogenic] in Lovd
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-89816615-T-G is Pathogenic according to our data. Variant chr16-89816615-T-G is described in ClinVar as [Pathogenic]. Clinvar id is 553521.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-89816615-T-G is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FANCANM_000135.4 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/43 ENST00000389301.8 NP_000126.2
FANCANM_001286167.3 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/43 NP_001273096.1
FANCANM_001018112.3 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/11 NP_001018122.1
FANCANM_001351830.2 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/10 NP_001338759.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FANCAENST00000389301.8 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/431 NM_000135.4 ENSP00000373952 P1O15360-1

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152024
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000250
AC:
3
AN:
120082
Hom.:
0
AF XY:
0.0000300
AC XY:
2
AN XY:
66718
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000858
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000475
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000292
AC:
4
AN:
1372060
Hom.:
0
Cov.:
31
AF XY:
0.00000295
AC XY:
2
AN XY:
677814
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000565
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000293
Gnomad4 SAS exome
AF:
0.0000128
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152024
Hom.:
0
Cov.:
34
AF XY:
0.0000135
AC XY:
1
AN XY:
74278
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.0000107
AC:
1

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group A Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingMyriad Genetics, Inc.Nov 16, 2021NM_000135.2(FANCA):c.1A>C(M1?) is an initiation codon variant classified as pathogenic in the context of Fanconi anemia complementation group A. M1? has been observed in cases with relevant disease (PMID: 29098742). Functional assessments of this variant are not available in the literature. M1? has been observed in population frequency databases (gnomAD: AMR 0.01%). In summary, NM_000135.2(FANCA):c.1A>C(M1?) is an initiation codon variant in a gene where loss of function is a known mechanism of disease and is predicted to disrupt protein function. Please note: this variant was assessed in the context of healthy population screening. -
Likely pathogenic, no assertion criteria providedcurationLeiden Open Variation DatabaseFeb 28, 2020Curator: Arleen D. Auerbach. Submitter to LOVD: Sue Richards. -
Fanconi anemia Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpSep 26, 2023This sequence change affects the initiator methionine of the FANCA mRNA. The next in-frame methionine is located at codon 116. This variant is present in population databases (rs772751654, gnomAD 0.009%). Disruption of the initiator codon has been observed in individuals with Fanconi anemia (PMID: 10090479, 15643609, 16084127, 23898106, 24584348). ClinVar contains an entry for this variant (Variation ID: 553521). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxDec 21, 2023Identified in patients with Fanconi anemia who also possessed another FANCA variant (PMID: 29098742); Initiation codon variant in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 10090479, 16084127, 24584348, 23898106, 29625052, 15643609, 29098742, 30031030, 30792206, 36451132) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Pathogenic
0.27
CADD
Benign
17
DANN
Benign
0.72
DEOGEN2
Benign
0.072
T;.;.;T;T;.
Eigen
Benign
-0.63
Eigen_PC
Benign
-0.64
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.90
D;D;D;D;D;D
M_CAP
Pathogenic
0.99
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D;D
MetaSVM
Benign
-0.47
T
MutationTaster
Benign
1.0
D;D;D;D
PROVEAN
Benign
-0.80
N;N;N;N;N;N
REVEL
Uncertain
0.32
Sift
Pathogenic
0.0
D;D;D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;D;D
Polyphen
0.064
B;.;.;.;B;B
Vest4
0.77
MutPred
1.0
Loss of phosphorylation at S2 (P = 0.1776);Loss of phosphorylation at S2 (P = 0.1776);Loss of phosphorylation at S2 (P = 0.1776);Loss of phosphorylation at S2 (P = 0.1776);Loss of phosphorylation at S2 (P = 0.1776);Loss of phosphorylation at S2 (P = 0.1776);
MVP
0.86
ClinPred
0.96
D
GERP RS
3.1
Varity_R
0.94
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs772751654; hg19: chr16-89883023; API